Osaic Holdings
ALT icon

Osaic Holdings’s Altimmune ALT Stock Holding History

Osaic Holdings’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.1K Buy
21,078
+400
+2% +$1.2K ﹤0.01% 5297
2026
Q1 		$63.7K Buy
20,678
+1,737
+9% +$7.38K ﹤0.01% 5025
2025
Q4 		$68.4K Buy
18,941
+1,193
+7% +$5.2K ﹤0.01% 5017
2025
Q3 		$67.8K Sell
17,748
-333
-2% -$1.29K ﹤0.01% 5097
2025
Q2 		$70K Sell
18,081
-1,607
-8% -$8.7K ﹤0.01% 4791
2025
Q1 		$98.4K Sell
19,688
-1,360
-6% -$8.62K ﹤0.01% 4182
2024
Q4 		$152K Buy
21,048
+5,933
+39% +$45.3K ﹤0.01% 3852
2024
Q3 		$92.8K Buy
15,115
+11,845
+362% +$80.2K ﹤0.01% 4280
2024
Q2 		$21.7K Sell
3,270
-63,965
-95% -$472K ﹤0.01% 5286
2024
Q1 		$684K Buy
67,235
+24,643
+58% +$251K ﹤0.01% 2681
2023
Q4 		$479K Buy
42,592
+39,151
+1,138% +$163K ﹤0.01% 3207
2023
Q3 		$8.95K Sell
3,441
-4,393
-56% -$12.6K ﹤0.01% 5975
2023
Q2 		$27.6K Buy
7,834
+3,416
+77% +$15.3K ﹤0.01% 5346
2023
Q1 		$18.5K Sell
4,418
-499
-10% -$5.93K ﹤0.01% 5612
2022
Q4 		$80K Sell
4,917
-6,420
-57% -$72.1K ﹤0.01% 4615
2022
Q3 		$145K Buy
11,337
+3,105
+38% +$45.8K ﹤0.01% 4044
2022
Q2 		$96K Buy
8,232
+8,226
+137,100% +$50.7K ﹤0.01% 4453
2022
Q1 		$0 Sell
6
-544
-99% -$4.01K ﹤0.01% 7209
2021
Q4 		$5K Sell
550
-1,660
-75% -$17.6K ﹤0.01% 6605
2021
Q3 		$26K Sell
2,210
-755
-25% -$9.18K ﹤0.01% 5576
2021
Q2 		$29K Sell
2,965
-8,898
-75% -$122K ﹤0.01% 5411
2021
Q1 		$167K Sell
11,863
-397
-3% -$6.42K ﹤0.01% 3904
2020
Q4 		$138K Buy
12,260
+5,259
+75% +$62K ﹤0.01% 3798
2020
Q3 		$92K Sell
7,001
-203
-3% -$4.06K ﹤0.01% 3882
2020
Q2 		$77K Sell
7,204
-200
-3% -$1.1K ﹤0.01% 3876
2020
Q1 		$24K Buy
+7,404
New +$17K ﹤0.01% 4491

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's ALT Position: Q2 2026 in Review

Osaic Holdings increased its Altimmune (ALT) stake by 1.9% in Q2 2026, buying an estimated $1.2K and bringing the position to 21,078 shares worth $64.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5297.

Osaic Holdings first reported a position in ALT in Q1 2020 and has held it in 26 quarters since. The position peaked at $684K in Q1 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Osaic Holdings held 21,078 shares of Altimmune worth $64.1K as of Q2 2026.
  • Osaic Holdings bought 400 Altimmune shares in Q2 2026, an estimated $1.2K.
  • Altimmune made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5297 holding.
  • Osaic Holdings first reported a position in Altimmune in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Altimmune position peaked at $684K in Q1 2024.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.